US Physical Therapy (NYSE: USPH) reported Q4 EPS of $0.64, $0.04 worse than the analyst estimate of $0.68. Revenue for the quarter came in at $117.3 million versus the consensus estimate of $121.48 million.

GUIDANCE:

US Physical Therapy sees FY2020 EPS of $2.98-$3.10, versus the consensus of $3.15.

Management currently expects the Company’s Operating Results for 2020 to be in the range of $38.1 million to $39.8 million or $2.98 to $3.10 per share. This earnings range is based on an assumed annual corporate tax rate of approximately 26.5%. Please note that the earnings guidance represents projected Operating Results from existing operations, including the acquisition announced today, and excludes future acquisitions. The 2020 earnings guidance range excludes expenses associated with the scheduled retirement and replacement of the Company’s CFO. The annual guidance figures will not be updated unless there is a material development that causes management to believe that Operating Results will be significantly outside the given range.

For earnings history and earnings-related data on US Physical Therapy (USPH) click here.